Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

Benjamin A. Fisher; Tonny Veenith; Daniel Slade; Charlotte Gaskell; Matthew Rowland; Tony Whitehouse; James Scriven; Dhruv Parekh; Madhu S. Balasubramaniam; Graham Cooke; Nick Morley; Zoe Gabriel; Matthew P. Wise; Joanna Porter; Helen McShane; Ling-Pei Ho; Philip N. Newsome; Anna Rowe; Rowena Sharpe; David R. Thickett; Julian Bion; Simon Gates; Duncan Richards; Pamela Kearns; on behalf of CATALYST investigators

doi:10.1101/2021.06.02.21258204

Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

View ORCID ProfileBenjamin A. Fisher, Tonny Veenith, Daniel Slade, Charlotte Gaskell, Matthew Rowland, View ORCID ProfileTony Whitehouse, James Scriven, Dhruv Parekh, Madhu S. Balasubramaniam, Graham Cooke, Nick Morley, Zoe Gabriel, Matthew P. Wise, Joanna Porter, Helen McShane, Ling-Pei Ho, Philip N. Newsome, Anna Rowe, Rowena Sharpe, David R. Thickett, Julian Bion, Simon Gates, Duncan Richards, Pamela Kearns on behalf of CATALYST investigators

doi: https://doi.org/10.1101/2021.06.02.21258204

Benjamin A. Fisher

1Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

2National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Benjamin A. Fisher
For correspondence: b.fisher{at}bham.ac.uk t.v.veenith{at}bham.ac.uk

Tonny Veenith

4Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: b.fisher{at}bham.ac.uk t.v.veenith{at}bham.ac.uk

Daniel Slade

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charlotte Gaskell

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew Rowland

6Kadoorie Centre for Critical Care Research, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tony Whitehouse

4Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Tony Whitehouse

James Scriven

7Department of Infectious Diseases, University Hospitals Birmingham NHS Trust, UK

8Institute of Microbiology and Infection, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dhruv Parekh

4Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

9Department of Respiratory Medicine, University Hospitals Birmingham NHS Trust, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Madhu S. Balasubramaniam

10Department of Critical Care Medicine, Royal Bolton Hospital, Bolton, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Graham Cooke

11Department of Infectious Disease, Imperial College London, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nick Morley

12Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zoe Gabriel

13Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew P. Wise

14Department of Critical Care Medicine, University Hospital of Wales, Cardiff, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joanna Porter

15Department of Respiratory Medicine, University College Hospital, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helen McShane

16The Jenner Institute, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ling-Pei Ho

17MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK

18Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philip N. Newsome

2National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

19Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Rowe

2National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rowena Sharpe

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David R. Thickett

5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

9Department of Respiratory Medicine, University Hospitals Birmingham NHS Trust, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julian Bion

4Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simon Gates

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Duncan Richards

20Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pamela Kearns

2National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

3Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplemenary Data[supplements/258204_file06.pdf]

View the discussion thread.

PreviousNext

Posted June 09, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

Benjamin A. Fisher, Tonny Veenith, Daniel Slade, Charlotte Gaskell, Matthew Rowland, Tony Whitehouse, James Scriven, Dhruv Parekh, Madhu S. Balasubramaniam, Graham Cooke, Nick Morley, Zoe Gabriel, Matthew P. Wise, Joanna Porter, Helen McShane, Ling-Pei Ho, Philip N. Newsome, Anna Rowe, Rowena Sharpe, David R. Thickett, Julian Bion, Simon Gates, Duncan Richards, Pamela Kearns

medRxiv 2021.06.02.21258204; doi: https://doi.org/10.1101/2021.06.02.21258204

Share This Article: